Drug Information

Drug General Information
Drug ID
D0X4VO
Former ID
DNC004626
Drug Name
N-[5-(Formyl-hydroxy-amino)-pentyl]-benzamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [526917]
Formula
C13H18N2O3
Canonical SMILES
C1=CC=C(C=C1)C(=O)NCCCCCN(C=O)O
InChI
1S/C13H18N2O3/c16-11-15(18)10-6-2-5-9-14-13(17)12-7-3-1-4-8-12/h1,3-4,7-8,11,18H,2,5-6,9-10H2,(H,14,17)
InChIKey
XZVIJIAWKVHBTR-UHFFFAOYSA-N
PubChem Compound ID
44359538
Target and Pathway
Target(s) Histone deacetylase 6 Target Info Inhibitor [526917]
KEGG Pathway Alcoholism
Viral carcinogenesis
Pathway Interaction Database Signaling events mediated by HDAC Class II
Signaling events mediated by HDAC Class I
Reactome NOTCH1 Intracellular Domain Regulates Transcription
Constitutive Signaling by NOTCH1 PEST Domain Mutants
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
Assembly of the primary cilium
WikiPathways Ectoderm Differentiation
Neural Crest Differentiation
Cell Cycle
References
Ref 526917Bioorg Med Chem Lett. 2004 Jan 19;14(2):449-53.Design, synthesis, and activity of HDAC inhibitors with a N-formyl hydroxylamine head group.
Ref 526917Bioorg Med Chem Lett. 2004 Jan 19;14(2):449-53.Design, synthesis, and activity of HDAC inhibitors with a N-formyl hydroxylamine head group.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.